|
Plasma cholesterol and triacylglycerol in hamsters treated with G. lucidum and lovastatin (mmol/L) |
||||||||
| Group |
TC |
TC |
TAG |
TAG |
VLDL |
LDL |
HDL |
LDL/HDL |
| D1 |
D18 |
D1 |
D18 |
D18 |
D18 |
D18 |
D18 |
|
|
|
||||||||
| Control |
3.57 |
3.48 |
1.10 |
1.08 |
0.22 |
0.51 |
2.75 |
0.19 |
| Lovastatin |
3.39 |
3.16a |
1.07 |
0.98 |
0.18a* |
0.48 |
2.50a |
0.19 |
| Gl (2.5%) |
3.46 |
3.40 |
0.64a |
0.90a |
0.18 |
0.53 |
2.69 |
0.20 |
| Gl (5%) |
3.34 |
3.14a* |
0.89a* |
0.92a |
0.20 |
0.49 |
2.44a* |
0.20 |
|
TC, total cholesterol; TAG, triacylglycerol; VLDL, LDL, HDL, very low-, low-, and high-density lipoproteins; D, day; LOVA, 20 mg/kg diet. Values represent mean of 6 animals. aSignificantly different from the control (P < 0.05 or *P < 0.10), students, unpaired, 1-tailed,t-test, equal variances. | ||||||||
Berger et al. Lipids in Health and Disease 2004 3:2 doi:10.1186/1476-511X-3-2 |
||||||||